🇺🇸 FDA
Pipeline program

fludeoxyglucose F 18

H-26701

Unknown other terminated

Quick answer

fludeoxyglucose F 18 for Lung Cancer is a Unknown program (other) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Lung Cancer
Phase
Unknown
Modality
other
Status
terminated

Clinical trials